Digipath
CHM Cannabis
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Fred- Those prescription numbers you posted also include

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
tilator Member Profile
 
Followed By 0
Posts 705
Boards Moderated 0
Alias Born 09/14/17
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/6/2018 11:18:22 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/6/2018 11:14:13 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/6/2018 6:11:40 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/30/2018 5:53:34 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/28/2018 2:44:21 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/28/2018 2:41:17 PM
GD Entertainment and Technology (GDET) Benefit from the transactional side of Bitcoin InvestorsHub NewsWire - 11/28/2018 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2018 5:37:11 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2018 3:38:31 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2018 3:24:23 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2018 3:20:56 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2018 3:17:34 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2018 8:12:16 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2018 6:10:06 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/21/2018 5:25:52 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/21/2018 5:23:41 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/21/2018 4:42:54 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/21/2018 12:05:37 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/21/2018 12:01:51 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/21/2018 6:06:39 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/6/2018 6:10:46 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/6/2018 6:10:14 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/6/2018 6:10:14 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/26/2018 4:30:50 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/26/2018 4:20:44 PM
tilator   Friday, 11/10/17 03:29:45 PM
Re: wimuskyfisherman post# 31192
Post # of 38227 
Quote:
Fred- Those prescription numbers you posted also include the standard Seroquel prescription as well as the XR. The standard prescriptions still far exceed the XR ones.



I suppose it has only XR:

"According to Symphony Health Solutions, sales of Seroquel XR® were approximately US$1.1 billion for the 12 months ending January 2017 (TRx MBS Dollars)."

http://www.intellipharmaceutics.com/product-detail.cfm?productID=118884

300k weekly prescriptions would make some US$1.5 billion sales if one prescription made US$100 sales.

I think there is really enough room for MNK sales, but do they take it seriously?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist